Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study

作者：Yi‐Long Wu, Yao Yu, Jin‐Ji Yang, Lin Wu, Wei Zhang, Ying Wang, Haipeng Xu, Yong Song, Yan Zhang, Jun Zhao, Jinghua Chen, Zhehai Wang, Qiming Wang, Jie Hu, Xingya Li, Yun Fan, Yuan Chen, Jian Fang, Di Han, Wei-Zhe Xue, Si‐Yang Maggie Liu, Qing Zhou, Pei-Long Zhang, He-Peng Shi · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(25)00594-7 · 被引用次数：6 · 研究领域：Lung Cancer Treatments and Mutations、Liver physiology and pathology、Lung Cancer Research Studies